Cargando…

Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report

BACKGROUND: Clarithromycin is an efficacious treatment for myeloma in combination with other anti-myeloma therapy but not as monotherapy. To date, all studies have focused on a clarithromycin-specific effect rather than a class effect (macrolide) and there is no information on the activity of roxith...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Kern Y., Byrne, Anna L., Morison, Ian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944102/
https://www.ncbi.nlm.nih.gov/pubmed/29743095
http://dx.doi.org/10.1186/s13256-018-1636-9